Key Details
Annual ROE
-21.81%Beta
-Events Calendar
Next earnings date:
N/ARecent quarterly earnings:
Nov 03, 2022Recent annual earnings:
Mar 16, 2022Next ex-dividend date:
N/ARecent ex-dividend date:
N/ANext split:
N/ARecent split:
July 25, 2022Analyst ratings
Recent major analysts updates
No data about analysts updates
Screeners with SYN included
No data
Market Data
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Dividend
Synthetic Biologics doesn't have historical dividend data
Profitability
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Efficiency
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cash Flow
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Institutional Ownership
Similar stocks
Instil Bio Announces Clinical Progress in China for IMM2510/SYN-2510, a Clinical-Stage PD-L1xVEGF Bispecific Antibody
SYN
globenewswire.com14 January 2025
ImmuneOnco announced dosing of first patient in its recently initiated Phase 1b/2 clinical trial of IMM2510/SYN-2510 in combination with chemotherapy in patients with advanced NSCLC in China
FAQ
- What is the primary business of Synthetic Biologics?
- What is the ticker symbol for Synthetic Biologics?
- Does Synthetic Biologics pay dividends?
- What sector is Synthetic Biologics in?
- What industry is Synthetic Biologics in?
- What country is Synthetic Biologics based in?
- When did Synthetic Biologics go public?
- Is Synthetic Biologics in the S&P 500?
- Is Synthetic Biologics in the NASDAQ 100?
- Is Synthetic Biologics in the Dow Jones?
- When was Synthetic Biologics's last earnings report?
- When does Synthetic Biologics report earnings?
What is the primary business of Synthetic Biologics?
Synthetic Biologics, Inc., a clinical-stage company, develops therapeutics to treat gastrointestinal (GI) diseases in the United States. Its lead product candidates include SYN-004 that has completed Phase II clinical trial designed to degrade commonly used intravenous beta-lactam antibiotics in GI tract for the prevention of microbiome damage, clostridium difficile infection (CDI), overgrowth of pathogenic organisms, the emergence of antimicrobial resistance (AMR), and acute graft-versus-host-disease in allogeneic hematopoietic cell transplant recipients; and SYN-020, a recombinant oral formulation for the enzyme intestinal alkaline phosphatase to treat both local GI and systemic diseases. The company also develops clinical stage products, such as SYN-006 and SYN-007 for the prevention of CDI, overgrowth of pathogenic organisms, and AMR; and SYN-005 for the prevention and treatment of pertussis. Synthetic Biologics, Inc. has collaborations with Intrexon Corporation, The University of Texas at Austin, and Cedars-Sinai Medical Center; and a clinical trial agreement with Washington University School of Medicine in St. Louis to conduct a Phase 1b/2a clinical trial of SYN-004. The company is headquartered in Rockville, Maryland.
What is the ticker symbol for Synthetic Biologics?
The ticker symbol for Synthetic Biologics is NYSE American:SYN
Does Synthetic Biologics pay dividends?
No, Synthetic Biologics does not pay dividends
What sector is Synthetic Biologics in?
Synthetic Biologics is in the Healthcare sector
What industry is Synthetic Biologics in?
Synthetic Biologics is in the Biotechnology industry
What country is Synthetic Biologics based in?
Synthetic Biologics is headquartered in United States
When did Synthetic Biologics go public?
Synthetic Biologics's initial public offering (IPO) was on 12 February 1993
Is Synthetic Biologics in the S&P 500?
No, Synthetic Biologics is not included in the S&P 500 index
Is Synthetic Biologics in the NASDAQ 100?
No, Synthetic Biologics is not included in the NASDAQ 100 index
Is Synthetic Biologics in the Dow Jones?
No, Synthetic Biologics is not included in the Dow Jones index
When was Synthetic Biologics's last earnings report?
Synthetic Biologics's most recent earnings report was on 3 November 2022
When does Synthetic Biologics report earnings?
The date for Synthetic Biologics's next earnings report has not been announced yet